Protein-Losing Enteropathy

In a patient with edema, ascites, pleural effusions, diarrhea, weight loss, or malabsorption plus low albumin or total protein, first establish whether hypoalbuminemia is disproportionate to hepatic synthetic dysfunction, urinary protein loss, or inadequate intake. The absence of proteinuria, liver disease, and malnutrition should prompt evaluation for protein-losing enteropathy (PLE). Wolters KluwerWolters KluwerProtein-Losing Enteropathy: An Uncommon Presentation of... : Official journal of the American College of Gastroenterology | ACG

Order fecal alpha-1 antitrypsin (A1AT) clearance to document enteric protein loss. A reported clearance greater than 24 mL/day is abnormal and supports PLE. WileyWileyDiagnostic dilemma in diagnosing rare cause of protein losing ... In Fontan series, a more stringent diagnostic construct required one compatible clinical feature plus albumin below 3.0 g/dL and either A1AT clearance above 50 mL/24 h or spot fecal A1AT above 100 mg/mL. jaccjaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan Operation Use the clearance rather than symptoms alone when the diagnosis will trigger invasive endoscopy, cardiac catheterization, or lymphatic intervention.

A positive A1AT result establishes nonselective gastrointestinal protein loss but does not identify the lesion. Determine whether the dominant branch is inflammatory mucosal injury, intestinal lymphatic disease, or a systemic hemodynamic process; each branch has different implications for endoscopy, imaging, and definitive therapy. PLE can include loss of albumin, immunoglobulins, and clotting factors, making severe cases clinically consequential beyond edema alone. jacc+1jaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan OperationjaccProtein-Losing Enteropathy in Patients With Congenital Heart Disease

An inflammatory or infiltrative mucosal pattern is favored by diarrhea with inflammatory stool markers, abdominal pain, bowel-wall thickening, or malabsorption. Elevated fecal calprotectin has been reported with diarrhea due to PLE, and chronic norovirus-associated common variable immunodeficiency enteropathy may combine elevated fecal calprotectin, steatorrhea, and increased fecal A1AT. NEJM+1NEJMNEJMcpc1913473_discussion_1WileyCVID Enteropathy Associated With Chronic Norovirus Infection ... Endoscopy with targeted biopsies should therefore follow confirmed PLE when this pattern is present, with pathology used to identify inflammatory bowel disease, celiac disease, infection, lymphoma, or another enteropathy.

Celiac disease is an actionable nonerosive cause of PLE. In a patient with hypoproteinemia and compatible gastrointestinal or nutritional features, include celiac disease in the biopsy and serologic evaluation rather than assuming that severe protein loss excludes a nonerosive disorder; reported PLE from celiac disease improved after initiation of a gluten-free diet. Wolters KluwerWolters KluwerProtein-Losing Enteropathy: An Uncommon Presentation of... : Official journal of the American College of Gastroenterology | ACG

A lymphatic pattern is favored by edema with diarrhea or steatorrhea, hypoalbuminemia, and lymphopenia. Primary intestinal lymphangiectasia reflects congenital lymphatic abnormalities, whereas secondary intestinal lymphangiectasia may result from congestive heart failure, constrictive pericarditis, Fontan circulation, cirrhosis, lymphatic tumors, inflammatory or infectious small-bowel disorders, lymphoma, or postirradiation fibrosis. Wolters Kluwer+1Wolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical GastroenterologyScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics Endoscopy may show visibly dilated lymphatics, and small-intestinal biopsy can show lymphatic dilation. ScienceDirectScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics

For secondary lymphangiectasia, do not stop after demonstrating dilated lymphatics: identify and reverse the obstructing or pressure-raising process when possible. Portal hypertension can produce secondary intestinal lymphangiectasia; in one reported case, Doppler ultrasound identified portal-hypertension features after echocardiography was essentially normal. Wolters KluwerWolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical Gastroenterology A cardiac history, signs of venous congestion, or prior Fontan procedure should redirect the workup toward hemodynamics rather than repeated empiric gastrointestinal therapy. jacc+2jaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan OperationWolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical GastroenterologyScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics

Admit or expedite specialist-directed evaluation when PLE is accompanied by tense ascites, symptomatic pleural or pericardial effusion, progressive edema, substantial weight loss, severe diarrhea, or rapidly declining albumin. These complications reflect the loss of albumin and may coexist with loss of immunoglobulins and clotting factors. jacc+1jaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan OperationjaccProtein-Losing Enteropathy in Patients With Congenital Heart Disease Track albumin and total protein serially, and reassess fluid burden and nutritional intake after each etiologic intervention.

When intestinal lymphangiectasia is demonstrated or strongly suspected, use dietary fat modification with medium-chain triglyceride supplementation as the physiologic bridge while the primary or secondary cause is addressed. Medium- and short-chain fatty acids can be transported directly through mesenteric venous blood, whereas impaired lymphatic drainage disrupts transport of long-chain dietary fat and fat-soluble vitamins. ScienceDirectScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics In a portal-hypertension-associated case, a low-fat diet with medium-chain triglyceride supplementation did not correct persistent hypoalbuminemia or elevated A1AT clearance, illustrating that dietary therapy does not substitute for correction of a sustained pressure-driven cause. Wolters KluwerWolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical Gastroenterology

Monitor for ongoing loss rather than relying on edema alone. In the Fontan cohort, PLE was associated with loss of albumin, immunoglobulins, and clotting factors. jaccjaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan Operation Falling albumin, recurrent effusions, persistent diarrhea, or continued elevation of fecal A1AT should trigger reassessment for an untreated inflammatory lesion, persistent lymphatic obstruction, or uncorrected Fontan or portal hemodynamic abnormality.

PLE occurs in approximately 5% to 15% of patients after modified Fontan operation and has historically been difficult to treat. jaccjaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan Operation Diagnose it with compatible clinical manifestations plus objective hypoalbuminemia and fecal A1AT elevation rather than attributing edema or diarrhea to Fontan physiology alone. In the cited cohort, diagnosis required at least one clinical feature, albumin below 3.0 g/dL, and either A1AT clearance above 50 mL/24 h or spot fecal A1AT above 100 mg/mL. jaccjaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan Operation

The workup must seek potentially modifiable cardiac and extracardiac contributors. Fontan PLE has been linked to abnormal hemodynamics, chronic lymphatic dilation, and inflammatory mechanisms; patients with more impaired hemodynamics may be less steroid-responsive, consistent with a more dominant lymphatic mechanism. jacc+1jaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan OperationScienceDirectThe Use of Oral Budesonide in Adolescents and Adults With Protein-Losing Enteropathy After the Fontan Operation - ScienceDirect Evaluate through a congenital heart disease team rather than treating presumed intestinal inflammation in isolation.

Budesonide, an enteric-specific corticosteroid, has been used successfully in Fontan-associated PLE in patients with preserved liver function, but the cited evidence does not specify a regimen or establish it as uniformly effective. jaccjaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan Operation Consider it only within a mechanism-directed plan and monitor albumin, symptoms, and fecal A1AT response. Persistent biochemical loss should prompt renewed evaluation for hemodynamic or lymphatic targets rather than indefinite empiric corticosteroid escalation. jacc+1jaccClinical Outcomes and Improved Survival in Patients With Protein-Losing Enteropathy After the Fontan OperationScienceDirectThe Use of Oral Budesonide in Adolescents and Adults With Protein-Losing Enteropathy After the Fontan Operation - ScienceDirect

Octreotide has been reported as an intestinal therapy for PLE after Fontan operation, but the available evidence does not define a standard dose, duration, or selection algorithm. AHA JournalsAHA JournalsDiagnosis and Management of Noncardiac Complications ... In a portal-hypertension-associated secondary lymphangiectasia case, a 10-day continuous octreotide infusion reduced neither persistent biochemical protein loss nor the need for definitive treatment. Wolters KluwerWolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical Gastroenterology Use this experience to avoid interpreting transient symptomatic improvement as correction of a pressure-driven lymphatic lesion.

For biopsy-defined inflammatory or infiltrative disease, treat the identified condition rather than PLE as a stand-alone diagnosis. Celiac-associated PLE has been managed with a gluten-free diet. Wolters KluwerWolters KluwerProtein-Losing Enteropathy: An Uncommon Presentation of... : Official journal of the American College of Gastroenterology | ACG For suspected inflammatory bowel disease, infection, lymphoma, or autoimmune enteropathy, pathology and targeted microbiologic or immunologic testing should determine therapy; fecal A1AT provides a measure of protein loss but not disease-specific treatment selection. Wolters Kluwer+2Wolters KluwerProtein-Losing Enteropathy: Case Illustrations and Clinical ... : Official journal of the American College of Gastroenterology | ACGWileyCVID Enteropathy Associated With Chronic Norovirus Infection ...ScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics

For secondary intestinal lymphangiectasia, prioritize reversal of the upstream disorder. Secondary causes include right heart failure, constrictive pericarditis, portal hypertension or cirrhosis, lymphoma, inflammatory or infectious small-bowel disease, and postirradiation fibrosis. Wolters Kluwer+1Wolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical GastroenterologyScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics In the reported portal-hypertension case, liver transplantation was followed by resolution of ascites and pleural effusion after dietary and octreotide measures had not normalized protein loss. Wolters KluwerWolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical Gastroenterology This supports escalation toward definitive correction when persistent lymphatic pressure is the dominant mechanism.

For primary intestinal lymphangiectasia, the diagnostic endpoint is anatomic confirmation and exclusion of secondary causes, because the same endoscopic and histologic lymphatic dilation can be produced by cardiac, hepatic, malignant, or inflammatory disease. Wolters Kluwer+1Wolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical GastroenterologyScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics Continue medium-chain triglyceride-based dietary management while monitoring clinical and biochemical response, but do not overlook a new secondary driver in adults or in patients with abrupt deterioration. Wolters Kluwer+1Wolters KluwerReversal of Protein-Losing Enteropathy by Liver... : Journal of Clinical GastroenterologyScienceDirectIntestine Lymphangiectasia - an overview | ScienceDirect Topics